Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study

Home > Science Hub > Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study
Back to the list

November 16, 2023

You might also be interested by

News

Strategic collaboration between Leica Biosystems and CellCarta: Advancing Precision Diagnosis and Treatment, Co-promoting the Development of Companion Diagnostics

March 24, 2025

More info

CellTalk Blog

The Role of Biomarkers and AI in the Future of Antibody-Drug Conjugates (ADCs)

March 17, 2025

More info

CellTalk Blog

How Antibody-Drug Conjugates (ADCs) Are Advancing Precision Cancer Treatment

February 18, 2025

More info

CellTalk Blog

Measuring Tumor Burden: Current and Emerging Approaches

January 24, 2025

More info